• Shop
  • Shopping cart
  • Contact Waters
  •  United States
    • China / 简体中文
    • Japan / 日本語
    • India / English
    • United Kingdom / English
    • Germany / Deutsch
    • France / Français
    • South Korea / 한국어
    • Canada / Français
    • Canada / English
    • Taiwan / 繁體中文
    • Brazil / Português
    • Italy / Italiano
    • Spain / Español
    • More...

Comprehending COVID-19: Reversed-Phase Liquid Chromatography (RPLC) of Intact SARS-CoV-2 Spike Protein

Library Number:
APNT135071700
Part Number:
720006907EN
Author(s):
Jennifer M. Nguyen, Matthew A. Lauber
Source:
Waters
Content Type:
Application Notes
Content Subtype:
Technical Notes
Related Products:
ACQUITY UPLC FLR Detector
 
Biopharmaceutical Discovery
 
ACQUITY UPLC I-Class PLUS System
 
Vion IMS QTof Ion Mobility Quadrupole Time-of-flight Mass Spectrometry
 
BioResolve RP mAb Polyphenyl Consumables
Abstract / Summary

The global COVID-19 pandemic has resulted in extensive efforts to develop vaccines for the novel coronavirus. Identifying vaccine targets relies on robust analytical methods to understand SARS-CoV-2 structural biology. This study focuses on reversed-phase liquid chromatographic analysis of the intact SARS-CoV-2 spike protein, which has emerged as a potential target for vaccine development due to its role in viral pathogenesis. This work demonstrates that using difluoroacetic acid (DFA) as a mobile phase modifier in place of formic acid (FA) results in increased chromatographic resolution during intact protein analysis. Furthermore, the results suggest that pairing this approach with N- and O-glycosidase treatments may enable more detailed intact protein MS investigations.


Downloadable File(s)
Title Format File Size
Download PDF PDF 422.29kB